Clinical Trials Insight: 700014603
Phase of Trial: Phase I
Latest Information Update: 09 Feb 2009
At a glance
- Drugs Davunetide (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Allon Therapeutics
- 07 Mar 2007 Status changed from in progress to completed.
- 31 Aug 2006 New trial record.